Brief: Edgewise Therapeutics Appoints Commercial Biotech Executive Christopher Martin To Its Board Of Directors
20/11/2025 13:12
Edgewise Therapeutics Inc EWTX.O: EDGEWISE THERAPEUTICS APPOINTS COMMERCIAL BIOTECH EXECUTIVE CHRISTOPHER MARTIN TO ITS BOARD OF DIRECTORS Source text: ID:nPn9k1YYZa Further company coverage: EWTX.O
Recent news on Edgewise Therapeutics
See all newsBrief: Edgewise Therapeutics Doses First Patient In Phase 2 Equinox-Hfpef Trial Of Edg-15400
Edgewise Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Edgewise Therapeutics Q2 net loss widens on higher expenses
Brief: Edgewise Therapeutics Q2 Operating Income USD -61.943 Million
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending